NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/08/2026
Voltar para busca
Dado oficial do USPTO
ISTURISA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
06/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
30/03/2016
Data de registro
18/10/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/02/2023
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Baar, CH
Examinador
SETTLES LEWIS, SHAILA E
Unidade examinadora
M50
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
RECORDATI AG
NOVARTIS AG
Representantes
Anthony P. Venturino VORYS, SATER, SEYMOUR AND PEASE LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics ; anti-fungal preparations ; antivirals ; cardiovascular pharmaceuticals ; dermatological pharmaceutical products ; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system ; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases ; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system ; pharmaceutical preparations for use in hematology and in tissue and organ transplantation ; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions ; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders ; pharmaceutical preparations for the prevention and treatment of kidney diseases ; pharmaceutical preparations for the prevention and treatment of diabetes ; pharmaceutical preparations for the prevention and treatment of hypertension ; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology ; pharmaceutical preparations for use in urology ; pharmaceutical products for ophthalmological use ; pharmaceutical products for the prevention and treatment of cancer and tumors ; Pharmaceutical preparations for the prevention and treatment of allergies ; pharmaceutical products for the prevention and treatment of bone diseases ; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
14/05/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/04/2026
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
18/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/12/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/12/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/12/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
20/11/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
13/10/2023
INPC
INVALIDATION PROCESSED
13/10/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/10/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/02/2023
71AG
REGISTERED-SEC.71 ACCEPTED
08/02/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2023
ES71
TEAS SECTION 71 RECEIVED
28/07/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
30/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/02/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/01/2017
FIMP
FINAL DISPOSITION PROCESSED
25/01/2017
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
17/11/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2016
PUBO
PUBLISHED FOR OPPOSITION
02/08/2016
NPUB
NOTICE OF PUBLICATION
13/07/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/06/2016
DOCK
ASSIGNED TO EXAMINER
21/06/2016
MAFR
APPLICATION FILING RECEIPT MAILED
18/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/06/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/06/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/06/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ISTURISA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.